Abstract:Macrocyclic peptides are predominantly peptide structures bearing one or more rings and spanning multiple amino acid residues. Macrocyclization has become a common approach for improving the pharmacological properties and bioactivity of peptides. A variety of ribosomal-derived and non-ribosomal synthesized cyclization approaches have been established. The biosynthesis of backbone macrocyclic peptides using seven new emerging methodologies will be discussed with regard to the features and strengths of each platform rather than medicinal chemistry tools. The mRNA display variant, known as the random nonstandard peptide integrated discovery (RaPID) platform, utilizes flexible in vitro translation (FIT) to access macrocyclic peptides containing nonproteinogenic amino acids (NAAs). As a new discovery approach, the ribosomally synthesized and post-translationally modified peptides (RiPPs) method involves the combination of ribosomal synthesis and the phage screening platform together with macrocyclization chemistries to generate libraries of macrocyclic peptides. Meanwhile, the split-intein circular ligation of peptides and proteins (SICLOPPS) approach relies on the in vivo production of macrocyclic peptides. In vitro and in vivo peptide library screening is discussed as an advanced strategy for cyclic peptide selection. Specifically, biosynthetic bicyclic peptides are highlighted as versatile and attractive modalities. Bicyclic peptides represent another type of promising therapeutics that allow for building blocks with a heterotrimeric conjugate to address intractable challenges and enable multimer complexes via linkers. Additionally, we discuss the cell-free chemoenzymatic synthesis of macrocyclic peptides with a non-ribosomal catalase known as the non-ribosomal synthetase (NRPS) and chemo-enzymatic approach, with recombinant thioesterase (TE) domains. Novel insights into the use of peptide library tools, activity-based two-hybrid screening, structure diversification, inclusion of NAAs, combinatorial libraries, expanding the toolbox for macrocyclic peptides, bicyclic peptides, chemoenzymatic strategies, and future perspectives are presented. This review highlights the broad spectrum of strategy classes, novel platforms, structure diversity, chemical space, and functionalities of macrocyclic peptides enabled by emerging biosynthetic platforms to achieve bioactivity and for therapeutic purposes.

Chemo-ribosomal synthesis of atropisomeric and macrocyclic peptides with embedded quinolines

Genetically programmed cell-based synthesis of non-natural peptide and depsipeptide macrocycles

Ribosomal Synthesis of Ketone-containing Peptide Backbone via O to C Acyl Shift

Biocompatible Synthesis of Macrocyclic Thiazol(in)e Peptides

Synthesis and Functionalization of Azetidine‐Containing Small Macrocyclic Peptides

Biosynthetic Strategies for Macrocyclic Peptides

Opportunities and Challenges from Current Investigations into the Biosynthetic Logic of Nosiheptide-Represented Thiopeptide Antibiotics

Current Synthetic Approaches to Peptide and Peptidomimetic Cyclization

Chemoenzymatic tandem cyclization for the facile synthesis of bicyclic peptides

Macrocyclization of Bioactive Peptides with Internal Thiazole Motifs Via Palladium-Catalyzed C–H Olefination

Tetrazine cyclized peptides for one-bead-one-compound library: Synthesis and sequencing

Solution- and Solid-Phase Macrocyclization of Peptides by the Ugi-Smiles Multicomponent Reaction: Synthesis of N-Aryl-Bridged Cyclic Lipopeptides

A Convenient Method for Synthesis of Tetraoxazole Peptide Macrocycles

Crafting Unnatural Peptide Macrocycles via Rh(III)-Catalyzed Carboamidation

Ribosome-mediated biosynthesis of pyridazinone oligomers in vitro

Selective Macrocyclization of Unprotected Peptides with an Ex Situ Gaseous Linchpin Reagent

Macrocyclic Peptide Construction Through C-H Activation Strategy.

Chemically revertible molecular clasps: Hydroxamic acid-mediated peptide macrocyclization and linearization

De Novo Sequencing of Synthetic Bis -cysteine Peptide Macrocycles Enabled by "Chemical Linearization" of Compound Mixtures

Biocompatible and Selective Generation of Bicyclic Peptides

Peptide Macrocyclisation via Intramolecular Interception of Visible-Light-Mediated Desulfurisation